Ajeet Kumar Gandhi on Muck Rack

Ajeet Kumar Gandhi

As seen in: eCancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ajeet Kumar

Contact Ajeet Kumar, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Prospective evaluation of locoregional control in oral cavity squamous cell carcinoma with lower or mid infratemporal fossa involvement treated with surgery and

|
By Prasoon Kumar Mishra, Rahat Hadi, Ajeet Kumar Gandhi
| eCancer
Purpose: Oral cavity squamous cell carcinoma (OCSCC) is the most prevalent malignancy of the head and neck malignancy in India. In locally advanced OCSCC, a combination of definitive surgery followed by postoperative radiotherapy (RT), with or without concurrent chemotherapy, offers superior oncologic outcomes compared to definitive chemoradiotherapy alone. The prognosis of T4b OCSCC with infratemporal fossa (ITF) involvement largely depended on the degree of invasion.
Open in Who Shared Issue with article?

Retrospective analysis of clinical outcome of 100 inoperable oral cavity carcinoma treated with definitive concurrent chemoradiotherapy with or without inductio

|
By Vachaspati Mishra, Ajeet Kumar Gandhi, Madhup Rastogi, Rakhi Verma
| eCancer
Objectives: The management of inoperable oral cavity squamous cell carcinoma (OCSCC) is onerous. We aimed to retrospectively analyse the outcome of our cohort of inoperable OC-SCC treated with definitive concurrent chemoradiotherapy (CTRT) with or without induction chemotherapy (IC). Methods: Data of 100 patients (January 2017 to May 2022) of histopathologically proven inoperable OC-SCC treated with definitive CTRT with weekly cisplatin 40 mg/m2 were retrieved from our departmental archives.
Open in Who Shared Issue with article?

Translational cancer research in India: Challenges and Promises

|
By Rath GK, Ajeet Kumar Gandhi, Madhup Rastogi, Gandhi AK
| ncbi.nlm.nih.gov
Skip to main page content Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software Editorial doi: 10.4103/jcrt.JCRT_1248_21.
Open in Who Shared View Duplicates (379) Issue with article?
See all 5 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Ajeet Kumar

Contact Ajeet Kumar, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified